Surfactant Positive Airway Pressure and Pulse Oximetry Trial

NCT00233324 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1316

Enrollment

NETWORK

Sponsor class

Conditions

Infant, Newborn, Diseases
Other Preterm Infants
Infant, Small for Gestational Age
Premature Birth
Bronchopulmonary Dysplasia
Retinopathy of Prematurity

Interventions

DRUG: Surfactant
DEVICE: Continuous Positive Airway Pressure (CPAP)
DRUG: Supplemental oxygen with target saturation of 85 to 89%
DRUG: Supplemental oxygen with target saturation of 91 to 95%

Sponsor

NICHD Neonatal Research Network

Collaborators

[object Object]
[object Object]
[object Object]